Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

交易中 02-06 12:39:34 EST

5.67

+0.04

+0.62%

最高5.83	最低5.58	成交量52.12万
今开5.78	昨收5.63	日振幅4.40%
总市值8.19亿	流通市值7.25亿	总股本1.45亿
成交额295.91万	换手率0.41%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":5.665,"timestamp":1770399571040,"preClose":5.63,"halted":0,"volume":521238,"delay":0,"changeRate":0.006216696269982263,"floatShares":128000000,"shares":144545700,"eps":-1.387123,"marketStatus":"交易中","change":0.035,"latestTime":"02-06 12:39:34 EST","open":5.78,"high":5.8276,"low":5.58,"amount":2959104.4562886,"amplitude":0.043979,"askPrice":5.67,"askSize":324,"bidPrice":5.66,"bidSize":588,"shortable":0,"etf":0,"ttmEps":-1.387123,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":2,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":5.63,"preHourTrading":{"tag":"盘前","latestPrice":5.83,"preClose":5.63,"latestTime":"09:24 EST","volume":2986,"amount":17309.096993,"timestamp":1770387861681,"change":0.2,"changeRate":0.035524,"amplitude":0.025879},"postHourTrading":{"tag":"盘后","latestPrice":5.8931,"preClose":5.63,"latestTime":"19:27 EST","volume":5486,"amount":30490.98,"timestamp":1770337635254,"change":0.2631,"changeRate":0.046732,"amplitude":0.06627},"volumeRatio":0.586696,"impliedVol":1.5059,"impliedVolPercentile":0.8685},"requestUrl":"/m/hq/s/ANNX","defaultTab":"news","newsList":[{"id":"2603984484","title":"Annexon, Inc.盘中异动 临近午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603984484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603984484?lang=zh_cn&edition=full","pubTime":"2026-01-16 00:37","pubTimestamp":1768495053,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日00时37分，Annexon, Inc.股票出现波动，股价大幅下跌5.01%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。公司的候选产品包括治疗自身免疫和神经退行性疾病的 ANX005，治疗眼科神经退行性疾病的 ANX007，口服小分子药物 ANX1502 以及治疗全身性自身免疫疾病的 ANX009。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116003734a4c868d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116003734a4c868d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"1100446037","title":"Annexon向欧洲药品管理局提交Tanruprubart治疗格林-巴利综合征的上市授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1100446037","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100446037?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:05","pubTimestamp":1767877536,"startTime":"0","endTime":"0","summary":"生物制药公司Annexon, Inc. (ANNX) 已正式向欧洲药品管理局(EMA)提交了其候选药物Tanruprubart的上市授权申请(MAA)，该药物拟用于治疗格林-巴利综合征(GBS)。此次提交标志着公司在推进该创新疗法于欧洲市场获批的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2601896528","title":"Annexon, Inc.盘中异动 股价大涨5.12%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601896528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601896528?lang=zh_cn&edition=full","pubTime":"2026-01-06 02:12","pubTimestamp":1767636741,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日02时12分，Annexon, Inc.股票出现异动，股价大幅上涨5.12%。截至发稿，该股报4.93美元/股，成交量326.799万股，换手率2.19%，振幅7.89%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.69%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106021221a49feba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106021221a49feba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"1129867125","title":"Annexon 宣布拟进行普通股和预付认股权证的公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1129867125","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129867125?lang=zh_cn&edition=full","pubTime":"2025-11-13 05:51","pubTimestamp":1762984289,"startTime":"0","endTime":"0","summary":"11月12日——Annexon Inc. 宣布：*ANNEXON 宣布拟进行普通股和预付认股权证的公开发行* ANNEXON INC - 启动7500万美元的普通股或预付认股权证公开发行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"1156199491","title":"Annexon公布2025年第三季度财务业绩、产品组合进展及关键里程碑预测","url":"https://stock-news.laohu8.com/highlight/detail?id=1156199491","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156199491?lang=zh_cn&edition=full","pubTime":"2025-11-11 05:06","pubTimestamp":1762808792,"startTime":"0","endTime":"0","summary":"Annexon公布2025年第三季度财务业绩、产品组合进展及关键里程碑预测","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2578757224","title":"Annexon, Inc.盘中异动 早盘快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578757224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578757224?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:58","pubTimestamp":1761314293,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时58分，Annexon, Inc.股票出现异动，股价急速拉升5.08%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Genenta Science Spa、Neuphoria Therapeutics Inc.、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2223.70%、1979.55%、1226.35%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genenta Science Spa、Neuphoria Therapeutics Inc.，振幅分别为69.66%、66.25%、63.95%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102421581397409454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102421581397409454&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2574432701","title":"Annexon, Inc.盘中异动 股价大跌5.06%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574432701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574432701?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:17","pubTimestamp":1760105867,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时17分，Annexon, Inc.股票出现波动，股价急速跳水5.06%。截至发稿，该股报3.10美元/股，成交量30.9735万股，换手率0.28%，振幅4.91%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102217489726aefd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102217489726aefd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2557330222","title":"Annexon, Inc.盘中异动 临近收盘股价大跌5.04%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557330222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557330222?lang=zh_cn&edition=full","pubTime":"2025-08-07 03:55","pubTimestamp":1754510106,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日03时55分，Annexon, Inc.股票出现波动，股价急速跳水5.04%。截至发稿，该股报2.36美元/股，成交量45.3634万股，换手率0.41%，振幅3.44%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703550794d402f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703550794d402f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2557633571","title":"Annexon, Inc.盘中异动 大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557633571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557633571?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:38","pubTimestamp":1754332718,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时38分，Annexon, Inc.股票出现异动，股价快速拉升5.10%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。其相关个股中，Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6378.21%、1463.29%、939.89%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023839a6d2d9bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023839a6d2d9bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2556472830","title":"Annexon, Inc.盘中异动 下午盘股价大跌5.02%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556472830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556472830?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:12","pubTimestamp":1753985529,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日02时12分，Annexon, Inc.股票出现波动，股价急速跳水5.02%。截至发稿，该股报2.46美元/股，成交量32.108万股，换手率0.29%，振幅5.15%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021209a46e0896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021209a46e0896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2555407270","title":"Annexon, Inc.盘中异动 大幅拉升5.04%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555407270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555407270?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:33","pubTimestamp":1753886010,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时33分，Annexon, Inc.股票出现波动，股价大幅拉升5.04%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。公司的候选产品包括治疗自身免疫和神经退行性疾病的 ANX005，治疗眼科神经退行性疾病的 ANX007，口服小分子药物 ANX1502 以及治疗全身性自身免疫疾病的 ANX009。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302233309727f9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302233309727f9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2518209991","title":"Annexon, Inc.盘中异动 股价大跌5.07%报2.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209991?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:51","pubTimestamp":1741629114,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时51分，Annexon, Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报2.62美元/股，成交量36.4619万股，换手率0.33%，振幅6.32%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311015154abf35ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311015154abf35ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2518447795","title":"Annexon, Inc.2024财年实现净利润-1.38亿美元，同比减少2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518447795?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449676,"startTime":"0","endTime":"0","summary":"3月9日，Annexon, Inc.公布财报，公告显示公司2024财年净利润为-1.38亿美元，同比减少2.99%；其中营业收入为0.00美元，每股基本收益为-1.01美元。从资产负债表来看，Annexon, Inc.总负债56.97百万美元，其中短期债务2.52百万美元，资产负债比为0.07，流动比率为0.11。机构评级：截至2025年3月9日，当前有5家机构对Annexon, Inc.目标价做出预测，其中目标均价为14.40美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef9896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef9896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX"],"gpt_icon":0},{"id":"2517877162","title":"Annexon, Inc.盘中异动 早盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517877162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517877162?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:26","pubTimestamp":1741274804,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时26分，Annexon, Inc.股票出现波动，股价快速跳水5.07%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232644989ebfd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232644989ebfd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2517944704","title":"Annexon, Inc.盘中异动 股价大涨5.06%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517944704?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:02","pubTimestamp":1741194120,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时02分，Annexon, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报2.60美元/股，成交量30.7254万股，换手率0.28%，振幅5.67%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010201a260f157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010201a260f157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2517601696","title":"Annexon, Inc.盘中异动 临近午盘快速拉升6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517601696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517601696?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:48","pubTimestamp":1741106901,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时48分，Annexon, Inc.股票出现异动，股价快速上涨6.28%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305004822a25f2a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305004822a25f2a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2516658291","title":"Annexon, Inc.盘中异动 早盘股价大跌5.11%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658291?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:55","pubTimestamp":1741017354,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时55分，Annexon, Inc.股票出现波动，股价快速下跌5.11%。截至发稿，该股报2.51美元/股，成交量21.8671万股，换手率0.21%，振幅9.09%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235555a25d5ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235555a25d5ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"1119217643","title":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)","url":"https://stock-news.laohu8.com/highlight/detail?id=1119217643","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119217643?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:14","pubTimestamp":1741007654,"startTime":"0","endTime":"0","summary":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)以上内容来自Benzinga Earnings专栏，原文如下：Annexon Q4 EPS $(0.33) vs $(0.36) YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANNX"],"gpt_icon":0},{"id":"2516364301","title":"Annexon, Inc.盘中异动 临近收盘股价大涨5.20%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516364301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516364301?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:52","pubTimestamp":1740775936,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时52分，Annexon, Inc.股票出现异动，股价急速上涨5.20%。截至发稿，该股报2.63美元/股，成交量80.7779万股，换手率0.76%，振幅8.20%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045216abe13de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045216abe13de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2514703421","title":"Annexon, Inc.盘中异动 临近收盘急速跳水5.16%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703421?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:39","pubTimestamp":1740429591,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时39分，Annexon, Inc.股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.67美元/股，成交量56.2921万股，换手率0.53%，振幅5.87%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504395198913d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504395198913d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com","stockEarnings":[{"period":"1week","weight":-0.1365},{"period":"1month","weight":0.1039},{"period":"3month","weight":0.9549},{"period":"6month","weight":1.3856},{"period":"1year","weight":0.5216},{"period":"ytd","weight":0.1215}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030084},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.058781},{"month":3,"riseRate":0.2,"avgChangeRate":-0.148136},{"month":4,"riseRate":0.2,"avgChangeRate":-0.074763},{"month":5,"riseRate":0.8,"avgChangeRate":0.002603},{"month":6,"riseRate":1,"avgChangeRate":0.126935},{"month":7,"riseRate":0.4,"avgChangeRate":0.110555},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.025343},{"month":9,"riseRate":0.833333,"avgChangeRate":0.131997},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.07122},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092843},{"month":12,"riseRate":0.5,"avgChangeRate":0.09677}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}